These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 11100005)
21. The glycoprotein IIb/IIIa receptor inhibitor (abciximab) in ST-segment elevation myocardial infarction. Mesquita A; Baptista J; Palos J; Seabra-Gomes R J Invasive Cardiol; 1999 Jun; 11(6):379-82. PubMed ID: 10745556 [TBL] [Abstract][Full Text] [Related]
22. Advances in antithrombotic therapy of acute myocardial infarction. Gensini GF; Comeglio M; Falai M Am Heart J; 1999 Aug; 138(2 Pt 2):S171-6. PubMed ID: 10426878 [TBL] [Abstract][Full Text] [Related]
23. Combination therapy for acute myocardial infarction: fibrinolytic therapy and glycoprotein IIb/IIIa inhibition. Califf RM Am Heart J; 2000 Feb; 139(2 Pt 2):S33-7. PubMed ID: 10650314 [TBL] [Abstract][Full Text] [Related]
24. Effects of GP IIb/IIIa inhibitors on vascular inflammation, coronary microcirculation, and platelet function. Kereiakes DJ Rev Cardiovasc Med; 2006; 7 Suppl 4():S3-11. PubMed ID: 17224889 [TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction. Nairooz R; Sardar P; Amin H; Swaminathan RV; Kim LK; Chatterjee S; Feldman DN Am J Cardiol; 2014 Jul; 114(2):250-9. PubMed ID: 24890986 [TBL] [Abstract][Full Text] [Related]
26. Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction. Patel VB; Moliterno DJ J Invasive Cardiol; 2000 Mar; 12 Suppl B():8B-15B. PubMed ID: 10731294 [No Abstract] [Full Text] [Related]
27. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study. Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719 [TBL] [Abstract][Full Text] [Related]
28. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial. Gurm HS; Lincoff AM; Lee D; Tang WH; Jia G; Booth JE; Califf RM; Ohman EM; Van de Werf F; Armstrong PW; Guetta V; Wilcox R; Topol EJ; J Am Coll Cardiol; 2004 Feb; 43(4):542-8. PubMed ID: 14975461 [TBL] [Abstract][Full Text] [Related]
29. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Fernandez JS; Sadaniantz A Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658 [No Abstract] [Full Text] [Related]